Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Cagrilintide Peptide Therapy: A New Era in Appetite Control and Weight Revolution Health & Wellness Understanding Cagrilintide: Benefits and Uses Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as